ER-KANG
3002673.012.73% ( +0.08 )
ER-KANG (300267)
Hunan Er-Kang Pharmaceutical Co., Ltd engages in the research and development, production, and sale of pharmaceutical excipients, APIs and finished drugs in Chi...
- Open
- 2.94
- High
- 3.04
- Low
- 2.94
- Prev. Close
- 2.93
- Volume
- 345.52K
- Turnover
- 103.65M
- Avg Price
- 3.00
- Bid/Ask Ratio
- --
- Amplitude
- 3.41%
- 52wk High
- 5.11
- Volume Ratio
- 0.68
- Turnover Ratio
- 1.68%
News
- London Stock Exchange · Jul 28 at 05:06 AM
REG - GSK PLC - Hansoh positive 2nd Phase III results for Riz-Rez
- Zhitong · Oct 29, 2025 at 05:47 AM
ER-KANG: The net profit for the third quarter was 1.9412 million yuan, a year-on-year increase of 106.11%
- Zhitong · Sep 29, 2025 at 08:05 AM
ER-KANG: The controlling shareholder plans to reduce its holdings by no more than 2.04%
- Zhitong · Aug 27, 2025 at 10:20 AM
ER-KANG released its performance for the first half of the year, with a net profit attributable to the parent company of 37.6346 million yuan, an increase of 497.36%
- Zhitong · Jul 28, 2025 at 05:20 AM
ER-KANG: Dihydroxypropyl Theophylline Injection approved for registration
- Zhitong · Jul 3, 2025 at 07:14 AM
ER-KANG's subsidiary plans to invest USD 10 million in a comprehensive formulation production project
